Fig. 2: Waterfall plots of tumor response and tumor shrinkage. | Nature Communications

Fig. 2: Waterfall plots of tumor response and tumor shrinkage.

From: Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial

Fig. 2: Waterfall plots of tumor response and tumor shrinkage.

a IRC assessment and b investigator assessment in the total pMMR population, and by c IRC assessment and d investigator assessment in the pivotal population–TRES. CPS combined positive score, CR complete response, IRC independent review committee, PD progressive disease, pMMR proficient mismatch repair, PR partial response, SD stable disease, TRES tumor response-evaluable set. Source data are provided as a Source data file.

Back to article page